Skip to main content
Clinical Trials/NCT05037175
NCT05037175
Active, Not Recruiting
N/A

Telehealth 2.0: Evaluating Effectiveness and Engagement Strategies for Asynchronous Texting Based Trauma Focused Therapy for PTSD

Stanford University3 sites in 1 country360 target enrollmentMarch 22, 2022

Overview

Phase
N/A
Intervention
Not specified
Conditions
Posttraumatic Stress Disorder
Sponsor
Stanford University
Enrollment
360
Locations
3
Primary Endpoint
PTSD Checklist for DSM-5 (PCL-5)
Status
Active, Not Recruiting
Last Updated
8 months ago

Overview

Brief Summary

There is a pressing need to increase capacity to treat PTSD related to or exacerbated by the COVID-19 pandemic. Texting-based therapy holds promise to increase capacity and reduce barriers to delivering evidence-based treatments (EBTs), but ongoing engagement in digital mental health interventions is low. This study will compare a texting-based EBT for PTSD to culturally-informed texting-based treatment for PTSD as usual, and it will also compare a unique incentive strategy to typical platform reminders aimed to prevent early discontinuation in therapy. This online study is open to individuals who live in 18 different states.

Detailed Description

The COVID-19 pandemic has exacerbated mental health challenges for trauma-exposed individuals due to increased isolation, insufficient capacity in the mental health workforce, and a predicted fourth wave of mental health impacts of the pandemic itself. There is a pressing need to increase treatment capacity. Digital mental health (DMH) interventions for posttraumatic stress disorder (PTSD) address well-documented barriers to traditional in-person psychotherapy or telehealth delivery of evidence-based treatments (EBTs) for PTSD, but many consumers do not remain engaged. Thus, acceptable, efficient, and engaging forms of EBTs are sorely needed, particularly for those who are less likely to access traditional psychotherapy or use online programs. Asynchronous texting therapy platforms may facilitate treatment engagement among those who seek discrete, convenient, and affordable support. In a pilot study of a texting-based format of an EBT for PTSD, Cognitive Processing Therapy (CPT-Text), CPT-Text was feasible to deliver, and clients showed substantially greater PTSD symptom improvement over a shorter time compared to text therapy as usual (TAU). A larger scale, more rigorous test is necessary. This is a randomized, Hybrid Type 1, effectiveness-implementation trial with a factorial design to compare text-based therapies for PTSD utilizing the HIPAA-compliant secure texting platform of our DMH partner, Talkspace. Participants will be enrolled in the study once they have consented, and competed the initial assessment, and determined to meet eligibility requirements. The study team will randomize participants (N= 360) who have PTSD that is related to, has been exacerbated, or developed during the COVID-19 pandemic into CPT-Text or text-based Culturally Informed Trauma Treatment As Usual (CITT). After approximately a week of onboarding with their therapist (e.g., introduction, establishing treatment goals, etc), the active texting intervention will begin and assessments will occur at established timepoints through 24 weeks after the active intervention begins. Active interventions will occur over the course of 12 weeks. Participants will also be randomized into one of two engagement strategies: therapist reminder as usual (RAU) or RAU + incentive (RI). The study will examine an innovative incentive structure in which the study will "pay it forward" by offering free or discounted therapy to other individuals with PTSD when participants remain engaged. The study will compare the impact of an engagement strategy on treatment response and engagement, and will examine motivation as a potential mechanism. The study will also evaluate a novel Natural Language Processing (NLP) or Large-Language Model (LLM) based approach to assessing CPT-Text fidelity. This study will (1) provide critical information about how to promote sustained DMH engagement using unique incentive strategies and moderators of engagement and outcomes and (2) offer first guidance on supporting quality and fidelity of messaging-based EBTs using computational methods.

Registry
clinicaltrials.gov
Start Date
March 22, 2022
End Date
June 29, 2026
Last Updated
8 months ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Shannon Wiltsey Stirman, PhD

Associate Professor of Psychiatry and Behavioral Sciences

Stanford University

Eligibility Criteria

Inclusion Criteria

  • Over the age of 18 residing in the United States
  • Criterion A event measured by the Life Events Checklist for DSM-5 (LEC-5)
  • Significant symptoms of PTSD as evidenced by a score of 33 or above on the PCL-5
  • PTSD symptoms that began or increased during the COVID pandemic (per self-report)
  • Registered/registering on Talkspace for messaging-based therapy
  • Ownership of a personal device for texting
  • Residence in a state with therapist capacity on the Talkspace platform

Exclusion Criteria

  • Acute risk for suicidal thoughts and/or behaviors measured by the Columbia Suicide Severity Rating Scale Lifetime-Recent Screen
  • Psychosis or substance abuse that requires prioritization of treatment and/or higher level of care

Outcomes

Primary Outcomes

PTSD Checklist for DSM-5 (PCL-5)

Time Frame: Baseline through 24 weeks

The PTSD Checklist for DSM-5 (PCL-5) is a 20-item self-report measure that evaluates the degree to which individuals have been bothered by PTSD symptoms tied to their most currently distressing event \[114\] . The monthly version will be administered at baseline and the weekly version thereafter.

Engagement-Completion

Time Frame: 13 Weeks

Completion of the intervention, defined as 13 weeks of CPT or CITT, or completion of all CPT modules, whichever comes first OR early completer (achievement of a PCL score below 20, which indicates good end-state functioning)

Secondary Outcomes

  • Patient Health Questionnaire (PHQ-9)(Baseline through 24 weeks)
  • The Brief Inventory of Psychosocial Functioning (B-IPF)(Baseline through 24 weeks)
  • The Client Satisfaction Questionnaire (CSQ)(Baseline through 24 weeks)
  • Working Alliance Inventory, Short Form (WAI-SF)(Week 1 through Week 12)
  • Behavioral Intention(Baseline through week 8)
  • Oppression-based traumatic stress inventory(Baseline through 24 weeks at 3 timepoints)
  • Post-traumatic Cognitions Inventory(baseline through 24 weeks, at 3 timepoints)
  • Self-Report Altruism Scale (SRA)(Baseline)
  • Cultural Humility Scale (CHS)(Week 1 through week 13, at 4 timepoints)
  • Cultural Missed Opportunities (CMO)(Week 1 through week 13, at 4 timepoints)
  • Engagement(13 weeks)
  • Adequate Dose of CPT(13 weeks)

Study Sites (3)

Loading locations...

Similar Trials